We started off last week with silver, and this week we’ve got another perspective on the white metal, which has grown by leaps and bounds this year, but remains under US$30 per ounce.


I spoke with David Smith of the Morgan Report and Money Metals, who said he sees a bright future for silver, and encouraged investors to be cautious about trading in and out of the market.

In his view, once silver can close above US$30 a couple of times, it will run up quickly, possibly leaving those who aren’t invested without another opportunity to get in. Overall, he emphasized that the current situation is not like silver’s “false bull run” in 2016 — it’s the real deal.

 

Silver Outlook 2021

   
Silver Price Outlook, Top Stocks and More! Download today!

“When this thing really gets underway and decides to challenge the high US$30s and into the US$40s, I don’t think it’s going to take any prisoners” — David Smith, the Morgan Report, Money Metals

I also spoke with Brian Leni of Junior Stock Review about how his portfolio has been doing this year. Describing the current environment as a “stock picker’s market,” he said the last six months have probably been the most profitable he’s seen in his life — he mentioned Abraplata Resource (TSXV:ABRA,OTC Pink:ABBRF) as his first 13 bagger.

Brian also discussed the dichotomy between the ideas he presents to his newsletter audience and the decisions he makes privately, saying that while he’s careful when it comes to recommendations for his followers he allows himself to be somewhat riskier when making his own personal trades.

“I’m much more conservative when it comes to my money and how I present it to my readers … on the other side of things, I do have a more speculative side to myself … and with my own money I’ll take some of those chances and do some shorter-term trades” — Brian Leni, Junior Stock Review

For our Twitter poll this week, we continued last week’s election theme. Normally a presidential election in the US is a fairly big talking point for the gold price, but this year it’s understandably been overshadowed by other factors.

With only about two months left before America goes to the polls, we asked our followers if a Donald Trump victory or a Joe Biden victory would be better for the gold price. By the time the poll closed, a narrow majority said they think a Trump victory would be more beneficial — although some commenters said they don’t think it will make a difference who wins.

We’ll be asking another question on Twitter next week, so make sure to follow us @INN_Resource or follow me @Charlotte_McL to share your thoughts!

Fear and Debt Push Gold to New Heights in 2020. What's coming in 2021?

 
Precious Metals Outlook INNvestor Report Download today!

In the cannabis space this week, INN’s Bryan Mc Govern had the opportunity to speak with Vic Neufeld, former CEO of Aphria (TSX:APHA,NASDAQ:APHA).

Vic left the major marijuana company in January 2019 citing health concerns, although his departure also came soon after a short seller report questioned Aphria’s Latin American acquisitions.

He’s now re-emerged as a director and advisor at Havn Life Sciences (CSE:HAVN), a new psychedelics company that went public this week. Explaining his interest in psychedelics, Vic cited their potential to help treat mental health issues as a key draw, and noted that research will be key moving forward.

“It’s something that we really need to have a better understanding of — the standardization, the efficacy, the safety (of psychedelics) so researchers … can take it to the next level” — Vic Neufeld, Havn Life Sciences

Vic won’t be involved with Havn’s day-to-day operations, which he said will help him better balance his work and home life. “In simple words, no more heavy lifting for me,” he explained.

Want more YouTube content? Check out our YouTube playlist At Home With INN, which features interviews with experts in the resource space. If there’s someone you’d like to see us interview, please send an email to cmcleod@investingnews.com.

And don’t forget to follow us @INN_Resource for real-time updates! 

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

 

Silver Outlook 2021

   
Silver Price Outlook, Top Stocks and More! Download today!

 Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.

For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.

Keep reading... Show less

The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities

– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .

Keep reading... Show less

Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.

Keep reading... Show less